Rexahn Pharmaceuticals (REXN) Stock News

The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 5) Abbott Laboratories (NYSE:...

Mentions: KURA PFE POAI SNDX ...

P/E Ratio Insights for Rexahn Pharmaceuticals

  Looking into the current session, Rexahn Pharmaceuticals Inc. (NASDAQ: REXN) shares are trading at $3.50, after a 23.11% increase. Moreover, over the...

SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm – MJCO, REXN, NTN, SUNW

NEW YORK, NY / ACCESSWIRE / August 22, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Majesco (NASDAQ:MJCO) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Thoma Bravo, L.P. for $13.10 per share. To learn more about your legal rights and options, visit:

Mentions: MJCO NTN SUNW

SHAREHOLDER ALERT: WeissLaw LLP Reminds MXIM and REXN Shareholders About Its Ongoing Investigations

Mentions: MXIM

SHAREHOLDER ALERT: WeissLaw LLP Reminds DLMV and REXN Shareholders About Its Ongoing Investigations

Mentions: DLMV

IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - REXN, DCOM, NGHC, INWK

NEW YORK, NY / ACCESSWIRE / July 25, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Ocuphire Pharma, Inc. To learn more about your legal rights and options, visit:

Mentions: ALL DCOM NGHC INWK

SHAREHOLDER ALERT: WeissLaw LLP Reminds DCOM and REXN Shareholders About Its Ongoing Investigations

Mentions: DCOM

SHAREHOLDER ALERT: Halper Sadeh LLP is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - MXIM, BFYT, ADSW, REXN

SHAREHOLDER ALERT: Halper Sadeh LLP is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - MXIM, BFYT, ADSW, REXN NEW YORK, NY / ACCESSWIRE / July 22, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the following mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information

Mentions: MXIM BFYT ADSW

ALERT: Halper Sadeh LLP is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - ADI, GRUB, REXN

Mentions: ADI GRUB

INVESTIGATION ALERT: Halper Sadeh LLP is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - GARS, NVTA, REXN

Mentions: GARS NVTA

ALERT: Halper Sadeh LLP Continues to Investigate Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - DCOM, REXN, MYOS

Mentions: DCOM MYOS

SHAREHOLDER ALERT: WeissLaw LLP Reminds REXN and DLMV Shareholders About Its Ongoing Investigations

Mentions: DLMV

INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Rexahn Pharmaceuticals, Inc.- REXN

LEGAL INVESTIGATION ALERT: Halper Sadeh LLP Announces It is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - MYOS, REXN

Mentions: MYOS

REXAHN PARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Rexahn Pharmaceuticals, Inc. - REXN

Rexahn Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether The Merger Of Rexahn Pharmaceuticals, Inc. Is Fair To Shareholders; Investors Are Encouraged To Contact The Firm

SHAREHOLDER ALERT: WeissLaw LLP Investigates Rexahn Pharmaceuticals, Inc.

Alpine Immune Sciences leads healthcare gainers; Brickell Biotech among losers

Gainers: Alpine Immune Sciences (NASDAQ:ALPN) +102%. Aethlon Medical (NASDAQ:AEMD) +94%. IVERIC bio (NASDAQ:ISEE) +24%. Eloxx Pharmaceuticals (NASDAQ:ELOX) +16%. Rexahn Pharmaceuticals (NASDAQ:REXN) +

Mentions: ALPN AEMD ISEE ELOX ...

ENPH, WLL among premarket gainers

Nova LifeStyle (NASDAQ:NVFY) +105%.TDH Holdings (NASDAQ:PETZ) +65%.Rexahn Pharmaceuticals (NASDAQ:REXN) +38% on announced merger with Ocuphire Pharma.Marin Software (NASDAQ:MRIN) +27%.China Xiangtai F

Mentions: NVFY PETZ MRIN PLIN

Rexahn Pharma up big on announced merger with Ocuphire Pharma (NASDAQ:REXN)

Rexahn Pharmaceuticals (NASDAQ:REXN) has agreed to merge with privately held Ocuphire Pharma, a developer therapies for eye disorders, in an all-stock deal.The combined company will do business as Ocu